- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Venmax Drugs and Pharmaceuticals Ltd — Board Meeting, 02-09-2025: Board Meeting
02-09-2025 | 01:57 pm
02-09-2025 | 01:57 pm
Venmax Drugs' board approved merging Hatri Pharma (Net Worth ~16.4 Cr, Revenue ~16.4 Cr) for efficiency gains. The board also approved increasing authorized share capital from 22 Cr to 60 Cr, pending shareholder approval. Big strategic moves ahead!
No comments yet. Be the first to comment!